Docebo is expanding into government and healthcare, with its first full federal sales cycle underway after receiving FedRAMP certification and plans to invest 10–12 employees in healthcare capabilities and compliance. The 365Talents acquisition strengthens Docebo's skills-management offering, helping it win bundled learning-and-skills contracts and increase enterprise deal sizes as customers paying at least CAD 100,000 now generate 56% of ARR. Enterprise momentum and product investment remain strong: Docebo expects ARR growth to improve, plans new AI tools such as Knowledge Search and AgentHub, and is targeting a 20% EBITDA margin in 2026 on the way to a medium-term goal of about 27%. 3 Stocks With High ROE and Market-Beating Growth Potential Docebo (NASDAQ:DCBO) is pursuing new growth initiatives across government, skills management, healthcare and artificial intelligence as it continues its shift toward larger enterprise customers, CFO Brandon Farber said at the Oppenheimer Technology Conference.
Farber described Docebo as a learning management system provider focused on "hybrid" use cases, serving organizations that need to train employees as well as external audiences such as customers, partners, members and associations. He said the company has differentiated itself in a fragmented LMS market by offering a platform designed to support both internal and external learning needs. → AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be Docebo has begun building out its presence in government and healthcare, two verticals that Farber said could provide additional growth opportunities. The company began focusing on state and local government last year and is entering its first full federal selling period following FedRAMP certification in 2025.
Farber said Docebo entered the third quarter with its largest government pipeline to date and has continued to exceed internal pipeline targets in the segment. Government remains a small portion of the company's annual recurring revenue base, but he said Docebo's aspirations for the vertical are above its previously stated target of 10% to 15% subscription CAGR. → Nebius' Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand However, he cautioned that federal opportunities can be unpredictable and lumpy, with larger contracts potentially closing in the current period or being delayed into 2027. Healthcare is the company's next verticalization effort.
Farber said healthcare already accounts for about 5% of Docebo's ARR, including several of its top 20 customers, despite the company not having historically tailored its offering to the industry. He said the company has identified lower win rates in healthcare because its platform has not fully addressed industry-specific compliance and workflow requirements. → On Holding's Price Stumble May Be an Opening for a Company Built to Run Docebo plans to invest approximately 10 to 12 employees across product, marketing and go-to-market functions over the next six to 12 months to develop its healthcare strategy. Farber cited pharmaceutical compliance requirements, including GxP compliance, as an example of the specialized capabilities needed to compete in the sector.
The company acquired 365Talents in January to add skills-management capabilities to its platform. Farber said the acquisition was driven by enterprise prospects seeking an integrated learning and skills solution, noting that Docebo had lost some enterprise opportunities in 2025 because it lacked a compelling skills offering. In the second quarter, Docebo won two customer contracts combining learning and skills, which Farber said the company likely would have lost the prior year.
He said the combined offering can increase contract value, using an illustrative example in which a CAD 100,000 LMS sale is paired with a CAD 100,000 skills sale. The first phase of product integration has been completed, with a second phase expected at the beginning of 2027. That phase is intended to create a more seamless experience with one login and two modules.
Extract — continue reading at the source.
